Clinical Trial

IV Iron Therapy for Older Adults With Heart Failure With Preserved Ejection Fraction and Iron Deficiency

Name: IV Iron Therapy for Older Adults With Heart Failure With Preserved Ejection Fraction and Iron Deficiency — clinical trial record (NCT07686692)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: INFUSE-HFpEF

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

This randomized, double-blind, placebo-controlled clinical trial evaluates intravenous ferric derisomaltose in older adults with HFpEF and iron deficiency.

Trial Details

NCT Number	NCT07686692
Lead Sponsor	Duke University Collaborators: National Institutes of Health (NIH), National Institute on Aging (NIA), Kaiser Permanente
Conditions	Heart Failure With Preserved Ejection Fraction, Iron Deficiency
Enrollment	300 participants
Start Date	2026-08
Primary Completion	2030-08 (estimated)
Study Completion	2030-08 (estimated)
Updated on ClinicalTrials.gov	2026-07-07